Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,470 | -1,884 | -870 | -514 | -1,965 |
| Depreciation Amortization | 63 | 7 | 5 | 2 | 4 |
| Accounts payable and accrued liabilities | 378 | 540 | 152 | 77 | 294 |
| Other Working Capital | 334 | 567 | 159 | 81 | 292 |
| Other Operating Activity | 58 | -401 | -58 | -28 | 141 |
| Operating Cash Flow | $-2,638 | $-1,171 | $-612 | $-381 | $-1,233 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3 | 3 | 3 | N/A | N/A |
| PPE Investments | -3 | -3 | -3 | -3 | -34 |
| Other Investing Activity | 0 | 0 | 0 | 18 | -60 |
| Investing Cash Flow | $0 | $0 | $0 | $15 | $-94 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 500 | N/A | N/A | N/A | 50 |
| Debt Issued | 1,501 | 500 | N/A | N/A | N/A |
| Common Stock Issued | 612 | 612 | 568 | 303 | 1,342 |
| Financing Cash Flow | $2,613 | $1,112 | $568 | $303 | $1,392 |
| Beginning Cash Position | 65 | 65 | 65 | 65 | 1 |
| End Cash Position | 41 | 7 | 21 | 2 | 65 |
| Net Cash Flow | $-24 | $-59 | $-44 | $-63 | $64 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,638 | -1,171 | -612 | -381 | -1,233 |
| Capital Expenditure | -3 | -3 | -3 | -3 | -34 |
| Free Cash Flow | -2,640 | -1,174 | -615 | -384 | -1,268 |